Stay updated on Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial page
- Check5 days agoChange DetectedThe revision history now shows v3.6.3 as the latest revision, replacing v3.6.2.SummaryDifference0.1%

- Check12 days agoChange DetectedRevision: v3.6.2 appears in the page footer, replacing v3.6.0, indicating a newer build of the Record History page.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA new note indicates recruitment is closed, updating the study's participation status. The history also shows a new revision tag (v3.6.0) and the removal of a previous revision (v3.5.5).SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer revision label was updated from v3.5.4 to v3.5.5, indicating a new build of the ClinicalTrials.gov history page; no changes to the study records themselves.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4 in the page footer, representing an updated version of the record history display.SummaryDifference0.1%

- Check69 days agoChange DetectedA new Revision: v3.5.3 entry was added to the record history, and the prior Revision: v3.5.2 entry was removed. This reflects an update to the page’s revision metadata rather than any changes to the trial data or results.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial page.